About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72640 record(s)
Req # EA2024_0080048
Request for information pertaining to Dartmouth COVE, and/or Atlantic Road Construction & Paving Ltd. For the period between January 1, 2022 and August 1, 2024Organization: Halifax Port Authority
September 2024
Req # A-2019-001618
Adverse Drug Reactions (ADRs) for FUROSEMIDE. Report numbers: E2B_02161856, 000724832, E2B_02229468, E2B_02235180, 000725717, 000724766, E2B_02215265.Organization: Health Canada
September 2024
Req # A-2021-001280
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106413-934.Organization: Health Canada
September 2024
Req # A-2021-002016
Adverse Drug Reaction (ADR). Report number: 000933471.Organization: Health Canada
September 2024
Req # A-2022-000459
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-108879-949.Organization: Health Canada
September 2024
Req # A-2023-000723
Adverse Drug Reactions (ADRs). Report numbers: E2B_05649767, E2B_02763747, 000972665, E2B_05628398, E2B_06216442, E2B_06186458, E2B_03293332, E2B_06030016, 001034630, E2B_06264505.Organization: Health Canada
September 2024
Req # A-2023-001039
Adverse Drug Reaction (ADR). Report number: E2B_06496077.Organization: Health Canada
September 2024
Req # A-2023-001309
Adverse Drug Reactions (ADRs). Report numbers: E2B_06451765, 1043220, E2B_06450183, 1050539, 1050563, 1052286, E2B_06566392, 1052822.Organization: Health Canada
September 2024
Req # A-2023-001333
Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06719295, E2B_06758044. ADR for Pantoloc. Report number: 001066050. ADRs for Pantoprazole sodium. Report numbers: E2B_06731244, E2B_06741613. ADRs for Tecta. Report numbers:…Organization: Health Canada
September 2024
Req # A-2023-001497
Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_06824978, E2B_06818170, E2B_06781412, E2B_06818361, E2B_06766936, E2B_06810905, E2B_06813780, E2B_06809546, E2B_06829661, E2B_06818363.Organization: Health Canada
September 2024